Metraipolis › archive › dc_2f3c499ee40a

Curing Sickle Cell Disease by Allogeneic Hematopoietic Stem Cell (HSC) Transplantation Toward In Vivo HSC Gene Therapy — Europe PMC PMID:41300819

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41300819
DOI
10.3390/genes16111367
License (as archived)
solo-consultazione
Archived
2026-11-08T16:19:07.097Z
SHA-256 of the archived text
1dd15d49f8eb23c93775dfa95c8376d4864b05221f6272eb8f7d0598c83c867a
Stable URL of this page
https://metraipolis.com/documento/dc_2f3c499ee40a

How to cite

Curing Sickle Cell Disease by Allogeneic Hematopoietic Stem Cell (HSC) Transplantation Toward In Vivo HSC Gene Therapy — Europe PMC PMID:41300819 — Europe PMC (en), https://europepmc.org/article/MED/41300819 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f3c499ee40a (Metraipolis archive dc_2f3c499ee40a, sha256 1dd15d49f8eb23c93775dfa95c8376d4864b05221f6272eb8f7d0598c83c867a)
BibTeX
@misc{dc2f3c499ee40a,
  title = {Curing Sickle Cell Disease by Allogeneic Hematopoietic Stem Cell (HSC) Transplantation Toward In Vivo HSC Gene Therapy — Europe PMC PMID:41300819},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41300819},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f3c499ee40a; sha256 1dd15d49f8eb23c93775dfa95c8376d4864b05221f6272eb8f7d0598c83c867a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41300819. Agents can read the archived copy with the MCP tool read_document.